Literature DB >> 25664116

Relationship between coronary artery disease and pulmonary arterial pressure in patients with chronic obstructive pulmonary disease.

Muntecep Asker1, Selvi Asker2, Ugur Kucuk3, Hilal Olgun Kucuk1, Bulent Ozbay4.   

Abstract

The aim of the present study was to determine whether there is a relationship between coronary artery disease and pulmonary hypertension and whether pulmonary hypertension is an additional risk factor for the presence and extent of coronary artery disease in patients with chronic obstructive pulmonary disease. Patients diagnosed with chronic obstructive pulmonary disease and pulmonary hypertension, and undergone diagnostic coronary angiography for evaluation of suspected coronary artery disease constituted the study group. Patients were divided into two groups according to the presence or absence of coronary artery disease and compared for age, gender, accompanying chronic disease, and pulmonary function tests. A total of 95 patients were recruited in the study. Comparison of the groups revealed that two groups were significantly different on gender (p=0.029), presence of hypertension (p=0.027), and biomass (p=0.040). Correlation analysis of variables revealed that male gender (rs=0.224, p=0.029), hypertension (rs=0.227, p=0.07) were positively correlated with the presence of coronary artery disease. FEV1/FVC ratio (rs=-0.253, p=0.013) and sPAP (rs=-0.215, p=0.037) were negatively correlated with the presence of coronary artery disease. High prevalence of coronary artery disease in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease was found. However, no correlation between the presence and severity of coronary artery disease and pulmonary hypertension was detected.

Entities:  

Keywords:  Coronary artery disease; chronic obstructive; hypertension; pulmonary; pulmonary disease

Year:  2014        PMID: 25664116      PMCID: PMC4307563     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

3.  Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease.

Authors:  G Celik; G Karabiyikoğlu
Journal:  Respiration       Date:  1998       Impact factor: 3.580

4.  The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis.

Authors:  Shin Matsuoka; Tsuneo Yamashiro; Alejandro Diaz; Raúl San José Estépar; James C Ross; Edwin K Silverman; Yasuyuki Kobayashi; Mark T Dransfield; Brian J Bartholmai; Hiroto Hatabu; George R Washko
Journal:  Acad Radiol       Date:  2010-10-13       Impact factor: 3.173

5.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Authors:  Salud Santos; Victor I Peinado; Josep Ramirez; Jaime Morales-Blanhir; Ricardo Bastos; Josep Roca; Robert Rodriguez-Roisin; Joan A Barbera
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

6.  Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

Authors:  Joan B Soriano; George T Visick; Hana Muellerova; Nassrin Payvandi; Anna L Hansell
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

8.  Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.

Authors:  M Oswald-Mammosser; E Weitzenblum; E Quoix; G Moser; A Chaouat; C Charpentier; R Kessler
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

9.  Inflammation and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Junichiro Takasu; Ronit Katz; David M Shavelle; Kevin O'Brien; Songshou Mao; J Jeffrey Carr; Mary Cushman; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2008-01-14       Impact factor: 5.162

10.  Coronary artery disease in the developing world.

Authors:  Karen Okrainec; Devi K Banerjee; Mark J Eisenberg
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

View more
  1 in total

1.  Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.

Authors:  Andreas Casselbrant; Artur Fedorowski; Sophia Frantz; Gunnar Engström; Per Wollmer; Viktor Hamrefors
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.